Meet our APAC team at BIO Japan in Yokohama & Partnering Conference in Osaka!
EU-Japan Biotech Pharma Partnering Conference, October 11, Osaka
BioJapan (October 12—14, Yokohama)
Newsroom
Meet SIRION Biotech at BioProcessing International in Boston!
Boston Convention and Exhibition CenterSeptember 27—30, Booth 631
Webinar: Identifying the Best AAV Vectors for Safer, More Potent, and Reliable Therapeutic Performance.
In this GEN webinar, our distinguished guests, Dr. Arun Srivastava and Dr. David Schaffer will tell...
SIRION Biotech Opens a New Viral Vector Research and Manufacturing Center!
We are pleased to announce that we are expanding! Our new state-of-the-art laboratories will be...
Panel Discussion at BIO 2022 – Safety Aspects of AAV and Lentivirus-based Cell and Gene Therapy
SIRION Biotech is pleased to host the panel discussion on Safety Aspects of AAV and...
Meet us at the 2022 Sociedad Española de Terapia Génica y Celular (SETGYC) meeting in Seviila, from 30 May to 1 June!
Dr. Francois Vromman and Dr. Monserrat Vazquez-Rojas will be there to discuss your viral vector...
SIRION Biotech to present at ASGCT 25th Anniversary Meeting
Graefelfing, Germany – Viral technology specialist SIRION Biotech will be a high profile presence...
Subscribe Here!
Contact Us
Whether you seek help customizing a vector for academic use or support for your industrial R&D, we will assist you from square one to discuss and plan your project in detail.
News
SIRION Biotech is now part of the Revvity portfolio!
SIRION Biotech licences its LentiBOOST® transduction technology to Cellectis
Meet us